BN: Yogurt Category Strength And Recall Handling Will Support Medium Term Resilience

Analysts have trimmed their blended fair value estimate for Danone by about €0.37 to €79.68, reflecting a combination of slightly firmer margin assumptions, a modestly lower future P/E, and recent price target moves such as BNP Paribas lifting its view to €83 and Morgan Stanley to €80, while others have taken a more cautious stance.

Analyst Commentary

Recent research on Danone reflects a split view, with some bullish analysts becoming more constructive on growth prospects in key categories and others turning more cautious on medium term execution and valuation risk.

Bullish Takeaways

Bullish analysts highlight what they see as healthy growth in the yogurt category, which they view as supportive for Danone's revenue trajectory and potential operating leverage over time.
The upgrade to a more positive rating with a price target of €83 signals confidence that current valuation leaves room for upside if the company delivers on its category growth and margin assumptions.
A higher price target of €80 from another bullish analyst suggests they see the risk or reward skew as favorable, backed by their comfort with the current P/E level versus their earnings outlook.
Supportive views on Danone's core categories imply that, if execution stays on track, the company could justify a premium to more cautious fair value marks used by other analysts.

Bearish Takeaways

Bearish analysts have reduced their price targets, which indicates concerns about how much investors are currently paying for Danone's earnings profile relative to their expectations.
The downgrade to a Sell rating with a €67 price target reflects a view that the shares may already price in optimistic assumptions on margins or growth, leaving less room for error.
Recent downward target moves from cautious analysts point to uncertainty around execution in European consumer staples over the coming years and how that might affect Danone's earnings resilience.
The spread between the lower bearish targets and the higher bullish ones underlines a debate on whether Danone can consistently deliver the growth and profitability needed to support higher valuation multiples.

What's in the News

Danone issued earnings guidance for 2026, indicating like for like sales growth is expected between 3% and 5%, with recurring operating income projected to grow faster than sales, in line with its stated mid term ambition (Corporate guidance).
The Board plans to propose a dividend of €2.25 per share for the 2025 fiscal year at the April 23, 2026 Annual Shareholders’ Meeting, which would be 4.7% above the prior year, with an ex dividend date slated for May 4, 2026 and payment on May 6, 2026 if approved (Dividend proposal).
Danone announced a targeted recall of specific infant formula batches in certain markets, stating that internal controls confirm products are safe and compliant, and that the withdrawal is to align with evolving guidance from local food safety authorities, with a consumer careline available for questions (Product related announcement).
Silk, a Danone brand, launched Silk Protein, a refrigerated plant based milk with 13g of complete plant protein per serving, 3g of fiber, calcium, vitamin D, and lower sugar than regular dairy milk, available in Original and Chocolate flavors in 48oz bottles at a suggested retail price of €5.99 equivalent, with nationwide rollout and further products planned (Product related announcement).
Danone started a share repurchase program on December 17, 2025, authorized to buy back up to 68,662,960 shares, or up to 10% of its share capital, at a maximum price of €85 per share over 18 months, for uses that include employee share plans, potential external growth transactions, share cancellations within legal limits, and liquidity support (Buyback announcement).

Valuation Changes

Fair Value: Trimmed slightly from €80.05 to €79.68, a small reduction of about €0.37.
Discount Rate: Held steady at 6.29%, indicating no change in the assumed cost of capital.
Revenue Growth: Adjusted marginally from 3.58% to 3.58%, effectively unchanged in practical terms.
Net Profit Margin: Nudged higher from 9.22% to 9.23%, reflecting a very small uplift in projected profitability.
Future P/E: Reduced from 22.07x to 21.49x, a modest step down in the multiple applied to expected earnings.

1 view

Key Takeaways

Focus on innovation, health-driven products, and strategic acquisitions solidifies Danone's leadership in premium nutrition and specialty segments amid changing consumer preferences.
Expanding in emerging markets and shifting towards digital and healthcare channels enhances growth opportunities, operational efficiency, and long-term margin stability.
Reliance on legacy products, operational inefficiencies, acquisition integration risks, currency volatility, and cost pressures from supply and regulation threaten Danone's sustained revenue and margin growth.

Catalysts

About Danone

Operates in the food and beverage industry in Europe, Ukraine, North America, China, North Asia, the Oceania, Latin America, rest of Asia, Africa, Turkey, the Middle East, and the Commonwealth of Independent States.What are the underlying business or industry changes driving this perspective?

Continued innovation and expansion in health-driven, functional foods and specialized nutrition-such as high-protein, probiotic, and medical nutrition products-positions Danone to capture above-market revenue growth as global consumers become increasingly focused on wellness and science-based nutrition.
Geographic broadening in emerging markets, especially across Asia, Africa, and Latin America, leverages rising urbanization and the growing middle class to expand Danone's addressable market and drive long-term revenue and volume gains.
Strategic investments and recent acquisitions (Kate Farms, The Akkermansia Company) strengthen Danone's leadership in plant-based, gut health, and medical nutrition, reinforcing differentiation and supporting both premiumization (higher revenue per unit sold) and improved long-term margin potential.
Early supply chain digitalization and increased operational productivity-evidenced by best-in-class manufacturing upgrades and cost discipline-are set to drive efficiency gains and support sustainable margin expansion, improving recurring operating income and overall earnings.
Shifting channel mix towards higher-growth segments, such as online/direct-to-consumer and specialized healthcare distribution, is expected to reduce reliance on traditional retail, increase brand control, and lift net margins and earnings resilience over time.

Danone Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Danone's revenue will grow by 3.0% annually over the next 3 years.
Analysts assume that profit margins will increase from 6.7% today to 9.1% in 3 years time.
Analysts expect earnings to reach €2.7 billion (and earnings per share of €4.25) by about September 2028, up from €1.8 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €2.4 billion.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 21.1x on those 2028 earnings, down from 26.1x today. This future PE is greater than the current PE for the GB Food industry at 11.4x.
Analysts expect the number of shares outstanding to decline by 0.08% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 5.98%, as per the Simply Wall St company report.

Danone Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Danone continues to rely heavily on traditional dairy and bottled water segments, and while functional and high-protein innovations are growing, slow improvement and inconsistent leadership in core categories, particularly dairy in major markets like the U.S. and Europe, could constrain long-term revenue growth if consumer trends shift further towards fresh, unprocessed, and locally sourced foods.
Structural challenges remain in North America, including execution issues and lagging plant-based brand performance (Silk), coupled with frustration from management about the speed of turnaround; this suggests ongoing operational inefficiencies and leadership uncertainty, which may suppress net margins and earnings if not fully resolved.
While Danone's recent acquisitions (e.g., Kate Farms, Akkermansia) show promise, there are inherent execution risks involved in integrating these businesses and extracting synergies-failure to successfully leverage these deals or deliver innovation at pace could result in one-off charges and increased volatility in earnings.
Persistent foreign exchange headwinds, particularly euro appreciation against the U.S. dollar and Chinese renminbi, have already offset like-for-like revenue growth, and ongoing currency volatility poses a material risk to both reported revenues and net profits, especially given Danone's broad geographic footprint.
Commodity and ingredient price volatility, exacerbated by climate change and global supply chain disruptions, remains a risk for Danone's cost of goods sold; combined with potential regulatory changes targeting plastics and carbon emissions, this could increase operating costs and ultimately erode margins if not proactively managed.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of €74.914 for Danone based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €85.0, and the most bearish reporting a price target of just €62.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €29.9 billion, earnings will come to €2.7 billion, and it would be trading on a PE ratio of 21.1x, assuming you use a discount rate of 6.0%.
Given the current share price of €74.32, the analyst price target of €74.91 is 0.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Danone?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Sustained Demand For Nutrition And Dairy Will Drive Global Market Gains